{"entity":{"id":"imagenomix","kind":"company","name":"Imagenomix","aka":[],"tldr":"Imagenomix, a spinout of NYU Langone, makes software that looks at a standard biopsy slide and predicts which cancer-driving mutations the tumour has, in minutes and without using up tissue, starting with lung cancer.","summary":"Imagenomix grew out of research at NYU Langone Health, where its founders, the pathologists Aristotelis Tsirigos, Matija Snuderl and Daniel Orringer, showed that AI could infer a tumour's driver mutations from H&E-stained slides. Its IGX Predict platform installs alongside digital pathology scanners and, according to NYU's launch announcement, returns a report to the doctor in about three minutes. The lung product, Pulmogene, is listed as commercial; a breast product (BLISS) is in development, and brain (NeuroInsight) and melanoma (DermPredict) products are on the roadmap. Travis Wold is chief executive.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://imagenomix.ai/"},{"label":"NYU Technology Opportunities and Ventures: launch announcement","url":"https://tov.med.nyu.edu/news/new-startup-imagenomix-launches-to-improve-access-to-cancer-testing/"}],"tags":[],"related":[],"cancers":["lung-cancer","breast-cancer"],"sections":["diagnostics","ai-computation"],"technologies":["ai-pathology-scoring","digital-pathology-ai"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Founding year not stated by the company; its timeline places commercial launch of IGX Predict in 2023 and NYU announced the startup's launch in about 2024. A USD 3.2 million seed round in May 2026, reported by GenomeWeb as led by Modi Ventures, could not be read in a primary source, so no funding row is recorded. Regulatory status of the products is not stated on the company website."],"hq":"New York, NY","country":"US","companyType":"ai-software","website":"https://imagenomix.ai/","stage":"startup","investors":[],"funding":[]},"route":"/companies/imagenomix/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"},{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"ai-pathology-scoring","kind":"technology","name":"AI scoring of biomarkers and grade on pathology slides","route":"/technologies/ai-pathology-scoring/"},{"id":"digital-pathology-ai","kind":"technology","name":"Digital pathology & AI","route":"/technologies/digital-pathology-ai/"}]}}